Short chain fatty acids mediates complement C1q pathway alleviation of perioperative neurocognitive disorders

IF 4.6 2区 医学 Q1 NEUROSCIENCES
Xiang Liu , Xiaona Tan , Yaozong Yu , Junfang Niu , Bo Zhao , Qiujun Wang
{"title":"Short chain fatty acids mediates complement C1q pathway alleviation of perioperative neurocognitive disorders","authors":"Xiang Liu ,&nbsp;Xiaona Tan ,&nbsp;Yaozong Yu ,&nbsp;Junfang Niu ,&nbsp;Bo Zhao ,&nbsp;Qiujun Wang","doi":"10.1016/j.neuropharm.2024.110266","DOIUrl":null,"url":null,"abstract":"<div><div>Perioperative neurocognitive disorders (PND) is one of the most common postoperative complications, which can lead to a harmful impact on self-dependence, longer hospital stays, increased medical costs, morbidity, and mortality amongst older adults. Microglia can modulate synapse elimination involved in the complement component protein 1q (C1q) pathway to induce cognitive dysfunction, which is significantly improved by short chain fatty acids (SCFAs) treatment. Here we investigate the effects of SCFAs treatment on PND via mediating C1q complement pathway. High-throughput sequencing of 16S rDNA from fecal samples of male SD rats was applied to assess the changes in gut microbiota. Fecal microbiota transplantation (FMT) was performed to investigate whether gut microbiota from PND rats could alter cognitive impairment. The blood from the rat tail vein was collected to measure the SCFAs concentrations. Hippocampal and brain tissue samples were obtained to perform Western blots, Golgi and immunofluorescence staining. Primary microglia treated with SCFAs or Histone deacetylase inhibitor were cultured to measure microglial activation states and the expression of acetylated histone. The 16S rDNA sequencing results showed that PND rats had the significant changes in the species diversity of the gut microbiota and the metabolite of specifc species. Gut microbiota from PND rats could alter spatial learning and memory, and meanwhile, the changed SCFAs concentrations in plasma were involved. The synapse elimination in PND rats was strikingly reversed by SCFAs treatment involved in modulation complement C1q via suppressing neuroinflammation. This suggests that a link between gut microbiota dysbiosis and cognitive function impairment is involved in synapse elimination via mediating complement C1q pathway. SCFAs treatment can alleviate PND, the mechanisms of which may be associated with regulating complement C1q pathway.</div></div>","PeriodicalId":19139,"journal":{"name":"Neuropharmacology","volume":"265 ","pages":"Article 110266"},"PeriodicalIF":4.6000,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0028390824004350","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Perioperative neurocognitive disorders (PND) is one of the most common postoperative complications, which can lead to a harmful impact on self-dependence, longer hospital stays, increased medical costs, morbidity, and mortality amongst older adults. Microglia can modulate synapse elimination involved in the complement component protein 1q (C1q) pathway to induce cognitive dysfunction, which is significantly improved by short chain fatty acids (SCFAs) treatment. Here we investigate the effects of SCFAs treatment on PND via mediating C1q complement pathway. High-throughput sequencing of 16S rDNA from fecal samples of male SD rats was applied to assess the changes in gut microbiota. Fecal microbiota transplantation (FMT) was performed to investigate whether gut microbiota from PND rats could alter cognitive impairment. The blood from the rat tail vein was collected to measure the SCFAs concentrations. Hippocampal and brain tissue samples were obtained to perform Western blots, Golgi and immunofluorescence staining. Primary microglia treated with SCFAs or Histone deacetylase inhibitor were cultured to measure microglial activation states and the expression of acetylated histone. The 16S rDNA sequencing results showed that PND rats had the significant changes in the species diversity of the gut microbiota and the metabolite of specifc species. Gut microbiota from PND rats could alter spatial learning and memory, and meanwhile, the changed SCFAs concentrations in plasma were involved. The synapse elimination in PND rats was strikingly reversed by SCFAs treatment involved in modulation complement C1q via suppressing neuroinflammation. This suggests that a link between gut microbiota dysbiosis and cognitive function impairment is involved in synapse elimination via mediating complement C1q pathway. SCFAs treatment can alleviate PND, the mechanisms of which may be associated with regulating complement C1q pathway.
短链脂肪酸介导补体 C1q 途径缓解围手术期神经认知障碍。
围手术期神经认知障碍(PND)是最常见的术后并发症之一,它会对老年人的自我依赖、住院时间延长、医疗费用增加、发病率和死亡率造成有害影响。小胶质细胞可以调节补体成分蛋白1q (C1q)通路的突触消除,诱导认知功能障碍,短链脂肪酸(SCFAs)治疗可显著改善认知功能障碍。本研究通过介导C1q补体途径探讨scfa治疗PND的作用。采用高通量测序法对雄性SD大鼠粪便样本中的16S rDNA进行测序,以评估肠道菌群的变化。采用粪便微生物群移植(FMT)研究PND大鼠肠道微生物群是否能改变认知障碍。取大鼠尾静脉血,测定SCFAs浓度。取海马和脑组织标本进行Western blot、高尔基体染色和免疫荧光染色。培养经SCFAs或组蛋白去乙酰化酶抑制剂处理的原代小胶质细胞,测定小胶质细胞的激活状态和乙酰化组蛋白的表达。16S rDNA测序结果显示,PND大鼠肠道菌群的物种多样性和特定物种的代谢物发生了显著变化。PND大鼠的肠道菌群改变了空间学习和记忆,同时也改变了血浆中scfa的浓度。通过抑制神经炎症调节补体C1q的scfa治疗显著逆转PND大鼠的突触消除。这表明肠道菌群失调与认知功能障碍之间的联系通过介导补体C1q途径参与突触消除。SCFAs治疗可缓解PND,其机制可能与调节补体C1q通路有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuropharmacology
Neuropharmacology 医学-神经科学
CiteScore
10.00
自引率
4.30%
发文量
288
审稿时长
45 days
期刊介绍: Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).
文献相关原料
公司名称
产品信息
索莱宝
trypsinization
索莱宝
penicillin
索莱宝
trypsinization
索莱宝
penicillin
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信